{"id":7340,"date":"2021-02-05T13:54:28","date_gmt":"2021-02-05T12:54:28","guid":{"rendered":"https:\/\/www.anderapartners.com\/?p=7340"},"modified":"2021-02-08T10:41:25","modified_gmt":"2021-02-08T09:41:25","slug":"andera-strengthens-governance-and-targets-e4-5-billion-in-aum-by-2025","status":"publish","type":"post","link":"https:\/\/www.anderapartners.com\/en\/andera-strengthens-governance-and-targets-e4-5-billion-in-aum-by-2025\/","title":{"rendered":"Andera strengthens governance and targets \u20ac4-5 billion in AUM by 2025"},"content":{"rendered":"

Andera Partners, an independent asset management firm specialising in private equity and operating through four specialist teams, Andera Life Sciences, Andera MidCap, Andera Expansion and Andera Acto, had an extremely busy year in 2020 despite the tough economic conditions, with \u20ac285 million in capital deployed, \u20ac148 million in sale proceeds received and \u20ac580 million in funds raised.<\/strong><\/p>\n

Supervisory Board strengthened by the appointment of three outstanding non-execs<\/strong><\/p>\n

\u00a0<\/strong><\/p>\n

We began 2021 with the appointment of three new non-executive directors to the Supervisory Board<\/strong> to lend additional strength to the partners in the governance of the firm. These outstanding appointees, who will actively contribute to the reputation and reach of Andera Partners, are Anne-France Malrieu<\/strong>, partner at Image<\/strong> 7<\/strong>, Christian Baillet<\/strong>, former Chairman and CEO of Quilvest, who will chair the Board,<\/strong> and Jean-Louis Laurens<\/strong>, former managing partner at Rothschild & Co.<\/strong> (see biographical notes at the end of this press release).<\/p>\n

\u20ac4-5 billion in assets under management by 2025<\/strong><\/p>\n

Assets under management (AUM) currently stand at \u20ac2.5 billion, having risen 25% in a year<\/strong> following two major fundraisings. ActoMezz IV, managed by Andera Acto, successfully raised \u20ac500 million in the middle of lockdown, while a further \u20ac80 million was raised for Cabestan Croissance, managed by Andera Expansion.<\/p>\n

In 2020, Andera Partners also kicked off the fundraisings for Cabestan Capital 3 (managed by Andera Expansion) and BioDiscovery 6 (managed by Andera Life Sciences), with target sizes of \u20ac220 million and \u20ac450 million respectively. Final closings will take place over the coming months.<\/p>\n

Fundraising for Andera MidCap 5, the successor fund to Winch Capital 4, will begin at the end of the first half of 2021. The target size is \u20ac600 million.<\/p>\n

 <\/p>\n

Andera Partners is aiming to reach \u20ac4-5 billion in assets under management by 2025<\/strong>. This target will be achieved both through organic growth<\/strong> and through the targeted recruitment of specialist staff<\/strong> who share the partnership vision, values and outstanding practical skills of the current Andera Partners teams.<\/p>\n

With these targets in mind, Andera Partners recruited nine new employees in 2020, increasing its total workforce to 75 people. Four investment staff were hired, while the support functions were bolstered by five new recruits, primarily in Investor Relations, Operations, and Finance and Digital.<\/p>\n

 <\/p>\n

Andera Partners\u2019 Action for Climate & Sustainability: ramping up our ESG strategy <\/strong><\/p>\n

Andera Partners gave extra momentum to its ESG strategy<\/strong> in 2020 with the establishment of an Action for Climate & Sustainability Committee. The Committee\u2019s mission is to coordinate all Andera Partners projects in this field, which are grouped around three main focus areas:<\/p>\n